# Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients

> **NCT00957385** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 24 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Revlimid

## Key facts

- **NCT ID:** NCT00957385
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00957385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00957385, "Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00957385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*